U2 Pf+
Payments companies reported to CMS as associated with U2 Pf+. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with U2 Pf+, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with U2 Pf+
These are the largest totals companies reported as associated with U2 Pf+. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Khalid Yousuf | Plano, TX | Orthopaedic Surgery | $10,252.93 |
| Gwo-Chin Lee | New York, NY | Orthopaedic Surgery | $8,839.23 |
| Nicholas Arnold | Fort Wayne, IN | Orthopaedic Surgery | $4,224.38 |
| Daniel Allison | Los Angeles, CA | Orthopaedic Surgery | $3,437.50 |
| Atul Kamath | Manasquan, NJ | Adult Reconstructive Orthopaedic Surgery | $2,768.75 |
| Harvey Montijo | Royal Palm Beach, FL | Orthopaedic Surgery | $2,500.00 |
| Lindsey Rolston | New Castle, IN | Orthopaedic Surgery | $1,622.50 |
| Mark Tuttle | Denver, CO | Adult Reconstructive Orthopaedic Surgery | $865.20 |
| Eric Slotkin | West Reading, PA | Orthopaedic Surgery | $322.76 |
| Peter Wood | Olympia, WA | Orthopaedic Surgery | $236.61 |
Prescribed U2 Pf+?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.